DV
Dividend Vision

ALMR — Alamar Biosciences, Inc. Common Stock

Alamar Biosciences, Inc. Common Stock (ALMR)

Total return is 95.1% over the past 0.3 years, 84.2 points ahead of SPY at 10.9%.

Alamar Biosciences is a proteomics company that develops and sells a liquid biopsy platform called NULISA technology, along with instruments, consumables, and services designed for early disease detection. The company's ARGO high-throughput system performs automated protein biomarker analysis for research applications in immunology, neurology, and oncology, serving research institutions, biopharmaceutical companies, and contract research organizations globally. The company does not currently distribute dividends and operates as a non-dividend-paying equity security.

ALMR key facts

Asset type
Stock
Asset class
Equity
Inception date
04/16/2026
Last close
$33.16
Market cap
$1,798,625,280
Average volume
161100.0
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.65